Partners

	PARTNER	COUNTRY		CONTACT PERSON			LOGO
	Institut de Ciència de Materials de Barcelona (ICMAB-CSIC) COORDINATOR	Spain		Dr. Gerard Tobias (Project coordinator) This email address is being protected from spambots. You need JavaScript enabled to view it.
	The University of Oxford (UOX)	United Kingdom		Prof. Benjamin G. Davis This email address is being protected from spambots. You need JavaScript enabled to view it.
	The University of Manchester (UNIMAN)	United Kingdom		Prof. Kostas Kostarelos This email address is being protected from spambots. You need JavaScript enabled to view it.
	King's College London (KCL)	United Kingdom		Dr. Khuloud Al-Jamal This email address is being protected from spambots. You need JavaScript enabled to view it.
	Universita Degli Studi di Trieste (UNITS)	Italy		Prof. Maurizio Prato This email address is being protected from spambots. You need JavaScript enabled to view it.     Dr. Tatiana Da Ros This email address is being protected from spambots. You need JavaScript enabled to view it.
	Centre National. de la Recherche Scientifique   (CNRS)	France		Dr. Alberto Bianco This email address is being protected from spambots. You need JavaScript enabled to view it.
	Catalan Institute of Nanotechnology  (ICN)	Spain		Dr. Belén Ballesteros This email address is being protected from spambots. You need JavaScript enabled to view it.
	University of Ioannina (UOI)	Greece		Dr. Dimitris Emfietzoglou This email address is being protected from spambots. You need JavaScript enabled to view it.
	Ustav Fyzikalni Chemie J. Heyrovskeho AV CR, v. v. i. (HIPC)	Czech Republic		Dr. Martin Kalbáč This email address is being protected from spambots. You need JavaScript enabled to view it.
	Cis Bio International Ion Beam Applications SA (IBA)	France/Belgium		Dr. Jean-Claude Saccavini This email address is being protected from spambots. You need JavaScript enabled to view it.
	Electron Microscopy for Materials Science Universiteit Antwerpen (EMAT-UA)	Belgium		Prof. Gustaaf Van Tendeloo This email address is being protected from spambots. You need JavaScript enabled to view it.

External Advisor

	INSTITUTION	COUNTRY	EMAIL				LOGO
	University of Oxford	United Kingdom	Prof. Malcolm L.H. Green FRS This email address is being protected from spambots. You need JavaScript enabled to view it.
	Chrysalium Consulting	France	Dr. Richard Zimmermann This email address is being protected from spambots. You need JavaScript enabled to view it.">This email address is being protected from spambots. You need JavaScript enabled to view it.

Project

RADDEL, an inter-sectorial European network formed by 11 partners from 7 different countries, has been awarded by the European Commission with a Marie Curie Initial Training Network (ITN) grant under the EU´s FP7 PEOPLE program. The network is formed by leading experts from Universities, Research Centers and Industry willing to share their complementary expertise, infrastructure and facilities for the training of the next generation of top-quality researchers through the development of new science. The project started in February 2012 and will run for 4 years.

The project focuses on the design, synthesis, characterization, pharmacological studies and dosimetry calculations of nanocapsules that contain in their interior radioactive materials for biomedical applications in the areas of cancer diagnosis and therapy. After sealing the chosen radionuclides, the external walls of the nanocapsules will be decorated with biomolecules to render them biocompatible and for targeting purposes. A well structured training program will be also provided with a balanced combination of local and network-wide training through secondments, joint network meetings, workshops, schools, industrial training and the final network conference.

While the training program has been designed to provide the fellows with the necessary expertise to improve their research skills and enhance their career prospects, the scientific program aims to develop novel nanomaterials for biomedical applications. The network expects to go beyond the state-of-the-art, trying to find innovative products and solutions in the field of cancer diagnosis and therapy.